Palvella Therapeutics, Inc. (FRA:PI6)

Palvella Therapeutics Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022
Period Ending	Dec 4, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Market Capitalization	1,022	130	-	-
Enterprise Value	982	208	-	-
PB Ratio	31.01	2.15	-	-
P/TBV Ratio	31.01	2.15	-	-
Debt / Equity Ratio	0.41	0.19	-2.08	-1.40
Quick Ratio	6.38	7.14	3.11	2.78
Current Ratio	6.49	7.33	3.20	2.86
Return on Equity (ROE)	-301.19%	-59.37%	-	-
Return on Assets (ROA)	-47.54%	-18.39%	-61.63%	-
Return on Capital (ROIC)	-63.87%	-22.38%	-110.58%	-
Return on Capital Employed (ROCE)	-55.90%	-18.50%	-228.80%	-167.90%
Earnings Yield	-2.70%	-12.95%	-	-
Buyback Yield / Dilution	-60.51%	-24.08%	68.63%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.